Results 221 to 230 of about 5,968,314 (298)

Treatment‐Related Adverse Events and Health‐Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

Head &Neck, EarlyView.
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell, E. C. Ward, L. R. Wishart, R. Perera, C. Barrett, K. A. Edmiston, E. Mitchell, A. Pigott, R. Pitt, K. Russell, B. A. Chan, R. Ladwa   +11 more
wiley   +1 more source

Sarcomatoid renal cell carcinoma masquerading as xanthogranulomatous pyelonephritis: a case report. [PDF]

Front Oncol
Hua C, Li T, Li X, Duan S.
europepmc   +1 more source

Proteomic Analysis Identifies Potential Biomarkers of ELOC -Mutated Renal Cell Carcinoma. [PDF]

Am J Surg Pathol
Fukagawa A, Arai Y, Maeshima A, Hama N, Totoki Y, Nakamura H, Saito-Adachi M, Hokazono Y, Nakamura E, Matsui Y, Adachi S, Hamamoto R, Ushiku T, Yachida S, Shibata T.   +14 more
europepmc   +1 more source

Pathologic Misclassification of Renal Cell Carcinoma in Adolescents and Young Adults. [PDF]

Cancers (Basel)
Stout M, Allison DB, Peard L, Cranford W, Feygin YB, McAbee K, McLouth CJ, Hensley PJ, Bylund JR, Buchanan AF.   +9 more
europepmc   +1 more source

Editorial: Unraveling renal cell carcinoma: pathogenesis, therapeutic strategies, and future perspectives. [PDF]

Front Med (Lausanne)
Guo W, Zuo D, Jiang X, Liu H, Zhou Z, Xu R.   +5 more
europepmc   +1 more source